TY - JOUR
T1 - Higher dietary lycopene intake is associated with longer cardiac event-free survival in patients with heart failure
AU - Biddle, Martha
AU - Moser, Debra
AU - Song, Eun Kyeung
AU - Heo, Seongkum
AU - Payne-Emerson, Heather
AU - Dunbar, Sandra B.
AU - Pressler, Susan
AU - Lennie, Terry
PY - 2013/8
Y1 - 2013/8
N2 - Background: The antioxidant lycopene may be beneficial for patients with heart failure (HF). Processed tomato products are a major source of lycopene, although they are also high in sodium. Increased sodium intake may counter the positive antioxidant effect of lycopene. Methods: This was a prospective study of 212 patients with HF. Dietary intake of lycopene and sodium was obtained from weighted 4-day food diaries. Patients were grouped by the median split of lycopene of 2471 μg/day and stratified by daily sodium levels above and below 3 g/day. Patients were followed for 1 year to collect survival and hospitalization data. Cox proportional hazards modeling was used to compare cardiac event-free survival between lycopene groups within each stratum of sodium intake. Results: Higher lycopene intake was associated with longer cardiac event-free survival compared with lower lycopene intake (p = 0.003). The worst cardiac event-free survival was observed in the low lycopene intake group regardless of sodium intake (> 3 g/day HR = 3.01; p = 0.027 and ≤ 3 g/day HR= 3.34; p = 0.023). Conclusion: These findings suggest that increased lycopene intake has the potential to improve cardiac event-free survival in patients with HF independent of sodium intake.
AB - Background: The antioxidant lycopene may be beneficial for patients with heart failure (HF). Processed tomato products are a major source of lycopene, although they are also high in sodium. Increased sodium intake may counter the positive antioxidant effect of lycopene. Methods: This was a prospective study of 212 patients with HF. Dietary intake of lycopene and sodium was obtained from weighted 4-day food diaries. Patients were grouped by the median split of lycopene of 2471 μg/day and stratified by daily sodium levels above and below 3 g/day. Patients were followed for 1 year to collect survival and hospitalization data. Cox proportional hazards modeling was used to compare cardiac event-free survival between lycopene groups within each stratum of sodium intake. Results: Higher lycopene intake was associated with longer cardiac event-free survival compared with lower lycopene intake (p = 0.003). The worst cardiac event-free survival was observed in the low lycopene intake group regardless of sodium intake (> 3 g/day HR = 3.01; p = 0.027 and ≤ 3 g/day HR= 3.34; p = 0.023). Conclusion: These findings suggest that increased lycopene intake has the potential to improve cardiac event-free survival in patients with HF independent of sodium intake.
KW - Lycopene
KW - antioxidants
KW - heart failure
KW - sodium
UR - http://www.scopus.com/inward/record.url?scp=84880884087&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880884087&partnerID=8YFLogxK
U2 - 10.1177/1474515112459601
DO - 10.1177/1474515112459601
M3 - Article
C2 - 23076979
AN - SCOPUS:84880884087
SN - 1474-5151
VL - 12
SP - 377
EP - 384
JO - European Journal of Cardiovascular Nursing
JF - European Journal of Cardiovascular Nursing
IS - 4
ER -